Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Equal Representation Act of 2025
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2026 · third_quarter · Q3
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Source: Senate LDA
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Medical Nutrition Therapy Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Improving Home Dialysis Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Kidney Disease Education Access Expansion Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Kidney Disease Education Access Expansion Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Medical Nutrition Therapy Act of 2026
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Comments on implementation of the Honor Our Living Donors Act changes to the Living Organ Donation Reimbursement Program. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. S. 4189 and H.R. 10227, the "Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 (INSULIN Act). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. H.R. 151, the "New Era of Preventing End-Stage Kidney Disease Act." Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
New Era of Preventing End-Stage Kidney Disease Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
CONNECT for Health Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Living Donor Protection Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Treat and Reduce Obesity Act of 2025
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Expanding Support for Living Donors Act of 2024
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Health Care Affordability Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Comments to Organ Procurement and Transplantation Network regarding Kidney Donor Profile Index (KDPI) without race and HCV. Comments to OPTN regarding Contractor Board relationships. Comments to OPTN on proposed Expedited Placement Variance. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits. Prescription drug pricing and access.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits. Prescription drug pricing and access.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Comments to Organ Procurement and Transplantation Network regarding Kidney Donor Profile Index (KDPI) without race and HCV. Comments to OPTN regarding Contractor Board relationships. Comments to OPTN on proposed Expedited Placement Variance. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
Living Donor Protection Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Comments on CY 2025 Advanced Notice of Changes to Medicare Advantage Capitation, Part C and Part D. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Expanding Access to Diabetes Self-Management Training Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Treat and Reduce Obesity Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Treat and Reduce Obesity Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Treat and Reduce Obesity Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Comments on CY 2025 Advanced Notice of Changes to Medicare Advantage Capitation, Part C and Part D. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Treat and Reduce Obesity Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Kidney PATIENT Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Kidney PATIENT Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Comments on CY 2025 Advanced Notice of Changes to Medicare Advantage Capitation, Part C and Part D. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Kidney PATIENT Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Kidney PATIENT Act of 2023
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Comments to Organ Procurement and Transplantation Network regarding Kidney Donor Profile Index (KDPI) without race and HCV. Comments to OPTN regarding Contractor Board relationships. Comments to OPTN on proposed Expedited Placement Variance. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
Honor Our Living Donors Act
Client: NATIONAL KIDNEY FOUNDATION · Firm: NATIONAL KIDNEY FOUNDATION
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits. Prescription drug pricing and access.
H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. H.R. 8875, the "Improving Home Dialysis Act of 2026" to address barriers to utilization of home dialysis. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. S. 3934 and H.R. 6199, the "Medical Nutrition Therapy Act of 2026" to expand Medicare Part B coverage for outpatient medical nutrition therapy (MNT) services. H.R. 7581, the "The Living Organ Volunteer Engagement Act, to establish a Medicare demonstration program for living kidney donor transplant facilitator training. Comments on Calendar Year 2027 ESRD Prospective Payment System. Comments on Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule. Protect and enhance to access to Medicaid, including comments on Interim Final Rule, Medicaid Program Community Engagement Requirement for Certain Individuals. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
FY 2027 Appropriations for organ donation and transplantation activities (HRSA). FY 2027 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2027 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2027 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2027 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2026 · second_quarter · Q2
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Comments to FDA re: Proposal to Withdraw Approval of New Drug Application for TAVNEOS (Avacopan). Support for xenotransplantation. Initiatives to improve chronic kidney disease early detection and management. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Support for access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Initiatives to expand access to home dialysis. H.R. 9509, the "Kidney Disease Education Access Expansion Act of 2026," to expand eligibility and utilization of the Medicare kidney disease education benefit and improve kidney disease detection. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for Medicare GLP-1 Bridge Program. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
FY 2027 Appropriations for organ donation and transplantation activities (HRSA). FY 2027 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2027 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2027 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2027 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2026 · first_quarter · Q1
FY 2026 and FY 2027 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 and FY 2027 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 and FY 2027 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 and FY 2027 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 and FY 2027 Appropriations for Indian Health Service.
Initiatives to expand access to home dialysis. Initiatives to expand eligibility and utilization of the Medicare kidney disease education benefit. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Comments on the Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. Comments on Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model. Comments on Organ Procurement Organizations (OPO) Conditions for Coverage Revision. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Comment letter in support for FDA approval of sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS). Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · fourth_quarter · Q4
FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 Appropriations for Indian Health Service.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Request to require inclusion of phosphorus on nutrition labels. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Support for xenotransplantation. Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care, including Affordable Care Act enhanced premium tax credits.
Initiatives to expand access to home dialysis. Request to Reinstate Race & Ethnicity Data Collection in the ESRD Quality Reporting System. S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Medicaid eligibility and affordability of coverage under the One Big Beautiful Bill. Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · third_quarter · Q3
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957); the Living Donor Protection Act (S.1552 and H.R. 4583); and legislation to clarify that organ donation surgery qualifies as a serious health condition for FMLA coverage (S. 1552, H.R. 4582). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. The New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518). Activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Support for telemedicine and telehealth access, including the CONNECT for Health Act (S.1261, H.R. 4206) for Medicare beneficiaries. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative. Outreach to CMS to request restoration of the collection of race and ethnicity data collection on Medicare beneficiaries with end stage renal disease. Comments on the Calendar Year Proposed Rules for the Medicare Physician Fee Schedule and Medicare Prospective Payment System.
FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Dept. of Defense Congressionally Directed Medical Research Program. FY 2026 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · second_quarter · 2A
FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Indian Health Service.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · second_quarter · Q2
FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2026 Appropriations for CDC, including the Chronic Kidney Disease Initiative. FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2026 Appropriations for Indian Health Service.
Activities to facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) to modify criteria to determine eligibility to reimburse individuals under the Living Organ Donation Reimbursement Program, and the Living Donor Protection Act (S.1552) to prohibit discrimination in life, disability and long-term health coverage policies. Comments on proposed "Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates," from the Organ Procurement and Transplantation Networks (OPTN) Disease Transmission Advisory Committee. Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. General activities in support of access to affordable, accessible health care. Opposed changes to Affordable Care Act eligibility, access and affordability under the One Big Beautiful Bill (H.R. 1).
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2025 · first_quarter · Q1
FY 2025 and FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2025 and FY 2026 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2025 and FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2025 and FY 2026 Appropriations for Indian Health Service.
Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2024 · fourth_quarter · Q4
FY 2025 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2025 Appropriations for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2025 Appropriations for the National Heart, Lung and Blood Institute. FY 2025 Appropriations under the Health Resources and Services Administration, with emphasis on organ donation and transplant activities. FY 2025 Appropriations for the Indian Health Service.
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." H.R. 10282, "Expanding Support for Living Donors Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments on National Institute of Minority Health and Health Disparities draft Strategic Plan. Comment on information collection request on Process Data for the Organ Donation and Transplantation Network (OPTN). Comments on revised HIV Organ Policy Equity Act Safeguards and Research Criteria.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2024 · third_quarter · Q3
FY 2025 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2025 Appropriations for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2025 Appropriations for the National Heart, Lung and Blood Institute. FY 2025 Appropriations under the Health Resources and Services Administration, with emphasis on organ donation and transplant activities. FY 2025 Appropriations for the Indian Health Service.
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Comments to CMS RFI on Alternative Payment Model Update and Increasing Organ Transplant Access (IOTA). Comments on CY 2025 Physican Fee Schedule and Medicare Shared Savings Program. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2024 · second_quarter · Q2
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits. Prescription drug pricing and access.
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2024 · first_quarter · Q1
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Comments to Organ Procurement and Transplantation Network regarding Kidney Donor Profile Index (KDPI) without race and HCV. Comments to OPTN regarding Contractor Board relationships. Comments to OPTN on proposed Expedited Placement Variance. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2023 · fourth_quarter · Q4
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Support for Medicare Part D Protected Classes. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" ESRD PPS Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES). Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
FY 2024 Appropriations for the Department of Health and Human Services programs. FY 2024 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2024 Appropriations for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. Funding for organ donation and transplant activities under HRSA and HHS. FY 2024 Appropriations for Indian Health Service.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2023 · third_quarter · Q3
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Support for Medicare Part D Protected Classes. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility, including comments on Medicaid Access to Services proposed rule. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" Comments on CY 2024 Physician Fee Schedule Comments on Medicare ESRD Prospective Payment System, ESRD Quality Incentive Program, ESRD Treatment Choices Model, and Dialysis Services for Acute Kidney Injury Comments on CMS Quality Measures website and development dashboard.
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544, "Securing the U.S. Organ Procurement and Transplantation Network Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Submitted comments to Organ Procurement and Transplantation Network (OPTN) Summer Comment Period on Living Donor Data Collection; Reporting Patient Safety Events; and Donor Support Data Collection. Activities regarding HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2023 · second_quarter · Q2
FY 2024 Appropriations for the Department of Health and Human Services programs. Funding increase for CDC Chronic Kidney Disease Initiative. Funding increase for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. Funding for organ donation and transplant activities under HRSA and HHS. FY 2024 funding for Indian Health Service.
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Support for Medicare Part D Protected Classes. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Treat and Reduce Obesity Act (introduction pending). S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" Recommended edits to Medicare and You Handbook update. Comments on Hospice RFI. Comments on Medicare Hospital Inpatient Prospective Payment System. Comments on Access to Coverage and Care in Medicaid RFI. Comments on CMS Quality Measures website and development dashboard.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2023 · first_quarter · Q1
Living Donor Protection Act (not yet introduced in 118th Congress), to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access. Activities regarding HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients, including but not limited to vaccinations and access to COVID medications and treatments. Activities to address ethnic, racial and social disparities in health and health care access, including comments to the National Institute of Diabetes and Digestive and Kidney Diseases working group Health Disparities and Health Equities Research draft report. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
Access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for staff-assisted home dialysis. Support for Medicare Part D Protected Classes. Medicare activities and coverage for COVID-19 patients. Medicare/Medicaid dual eligibility. Comments to Senate HELP Committee on workforce shortages. Treat and Reduce Obesity Act (pending introduction). Comments to ESRD Quality Incentive Program Study of Quality and Patient Experience. Comments on ESRD Medical Evidence Report (CMS-2728 form). Comments on Proposed Rule/RFI: Advancing Interoperability and Improving Prior Authorization. Comments on Advanced Notice for Calendar Year 2024 Medicare Advantage Capitation Rates and Part C and Part D Payment. Proposed Rule for Contract Year 2024 Policy Changes to Medicare Advantage and Prescription Drug Programs.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2022 · fourth_quarter · Q4
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. H.R. 8594 and S. 4750, "Restore Protections for Dialysis Patients Act," to provide Medicare access to kidney dialysis. Letter to HHS regarding Final Rule for the Medicare Part B-ID benefit to extend eligibility of coverage of immunosuppressive drugs for kidney transplant recipients for Medicare ESRD beneficiaries. Support for Protected Classes under Medicare Part D program. S. 4873, Improving Access to Advance Care Planning Act for Medicare advanced care planning. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. Support for Kidney Health Evaluation (KED) for patients with diabetes. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Participated in health community effort to urge HHS to expand Medicare coverage to include medically necessary dental treatments for solid organ transplant recipients and other vulnerable individuals.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2022 · third_quarter · Q3
Initiatives to increase, improve and facilitate organ donation and transplantation. S. 377 and H.R. 1255, the "Living Donor Protection Act," to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. H.R. 7506, "The New Era of Preventing End Stage Renal Disease Act." Activities to address COVID-19 impact and needs of kidney patients and caregivers, including supply change disruptions; prioritization for access to vaccination for dialysis patients and kidney transplant recipients; and, priority access to specific COVID-19 prescriptions. Issued Position Statement on White House Conference on Hunger, Nutrition, and Health. Healthy People 2030. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care and in chronic kidney disease detection, prevention, management and care. Activities included H.R. 7585, the Health Equity and Accountability Act (HEAA). H.R. 5030/S.2706, DIVERSE Trials Act to address clinical trails participation barriers by underrepresented patient populations. H.R. 7667, PDUFA reauthorization (support for clinical trial diversity provisions). Expand access to telemedicine. Support for limits on insulin prices for consumers. Prescription drug pricing and access. Affordable Care Act access and utilization.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2022 · second_quarter · Q2
FY 2023 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding for a Chronic Kidney Disease Risk Campaign public awareness initiative. Increase funding for CDC's Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA. Support for HHS Consumer Assistance Program funding to provide navigator and other educational resources.
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. Support for Kidney Health Evaluation (KED) for patients with diabetes. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Participated in health community effort to urge HHS to expand Medicare coverage to include medically necessary dental treatments for solid organ transplant recipients and other vulnerable individuals. Submitted written comments on the Proposed Rule to implement the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353, 116th Congress) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications. Submitted comments on the Proposed Calendar Year 2023 Inpatient Prospective Payment System (IPPS) rule. Wrote individual Medicare Administrative Contractors (MACs) to request they align their policies to implement the routine and timely use of Cystatin C to assess kidney function.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2022 · first_quarter · Q1
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Recommendations on the rulemaking process to implement the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353, 116th Congress) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications. Submitted comments on the Advanced Notice for Calendar Year 2023 for Medicare Advantage Capitation Rates and Medicare Part C and Part D Payment Policies.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · fourth_quarter · Q4
FY 2022 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding of a Chronic Kidney Disease Risk Campaign public awareness initiative. Increase funding for CDC's existing Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA.
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. Expand patients access to telemedicine. Submitted comments on Healthy People 2030. Signed health coalition comments letter on HHS Strategic Plan for FY 2022-2026. Support for the Advanced Research Projects Agency for Health (ARPA-H) Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · third_quarter · Q3
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access, including S. 1512 and H.R. 2903, "CONNECT for Health Act." Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care in general and in chronic kidney disease detection, prevention, management and care. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act." Prescription drug pricing and access. Affordable Care Act access and utilization. 21st Century Cures draft legislation.
Support for Protected Classes under Medicare Part D program. H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021." Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · second_quarter · Q2
FY 2022 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding of a Chronic Kidney Disease Risk Campaign public awareness initiative. Support for CDC's existing Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA.
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to improve access to and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Letter of support for S. 596 and H.R. 1577, the Treat and Reduce Obesity Act. Letter of support for S. 1024 and H.R. 2255, the Healthcare Workforce Resiliency Act. Prescription drug pricing and access. Affordable Care Act access and utilization.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2021 · first_quarter · Q1
FY 2022 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding of a Chronic Kidney Disease Risk Campaign public awareness initiative. Support for CDC's existing Chronic Kidney Disease program. Kidney disease research supported by NIH. Increase funding for kidney disease research. Funding for organ transplant activities under HHS and HRSA.
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers).
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · fourth_quarter · Q4
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
FY 2021 Appropriations for the Department of Health and Human Services (HHS,NIH,NIDDK,CDC,HRSA); Food and Drug Administration; Indian Health Service, Department of Veterans Affairs, Department of Defense. Request for HHS funding to support a proposed Chronic Kidney Disease "risk campaign" public awareness initiative. Funding to support various kidney disease and organ donations activities under HHS agencies. General Appropriations for FDA, IHS,DoD medical research, Veterans Affairs medical research.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · third_quarter · Q3
FY 2021 Appropriations for the Department of Health and Human Services (HHS,NIH,NIDDK,CDC,HRSA); Food and Drug Administration; Indian Health Service, Department of Veterans Affairs, Department of Defense. Request for HHS funding to support a proposed Chronic Kidney Disease "risk campaign" public awareness initiative. Funding to support various kidney disease and organ donations activities under HHS agencies. General Appropriations for FDA, IHS,DoD medical research, Veterans Affairs medical research.
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Medicare Hospital Inpatient Prospective Payment System and Medicare and Medicaid Interoperability Programs Requirements. Comments on Medicare ESRD Prospective Payment System and Quality Incentive Program. Comments on Medicare Physician Fee Service and Quality Payment Program. Increased use of Kidney Discards for transplantation. Access of medications under Medicare Part D Protected Classes.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · second_quarter · Q2
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis and other home health benefits Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353) Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Comments on Proposed Rule for changes to Medicare Advantage (including enrollment of ESRD patients), Medicare prescription drug program, and Medicare Cost Plan Program Comments on Origin and Destination Requirements under the Ambulance Fee Schedule Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Support for H.R. 6971, Medical Nutrition Therapy Act
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis (including patients with acute kidney injury), access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Video conference discussion with HRSA Division of Transplantation to discuss various issues surrounding organ donation Comments on proposed expansion of reimbursement of travel and subsistence expenses associated with living organ donation Prescription Drug Pricing and Access Management of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2020 · first_quarter · Q1
FY 2021 Appropriations for the Department of Health and Human Services (HHS,NIH,NIDDK,CDC,HRSA); Food and Drug Administration; Indian Health Service, Department of Veterans Affairs, Department of Defense. Request for HHS funding to support a Chronic Kidney Disease public awareness initiative.
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Early detection and management of Chronic Kidney Disease Department of Health and Human Services KidneyX initiative Comments on Organ Procurement Organization Conditions of Coverage for Outcomes Measures Comments on proposed revisions to living organ donor financial assistance Prescription Drug Pricing and Access Management of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · fourth_quarter · Q4
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534) Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
FY 2020 Appropriations for the Department of Health and Human Services (HHS, NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · third_quarter · Q3
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · second_quarter · Q2
FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2019 · first_quarter · Q1
FY 2019 and FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); funding for the National Living Donor Assistance Center; increased utilization of Kidney Discards Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Prescription Drug Pricing and Access Comments on Healthy People 2030 Management of the Patient Protection and Affordable Care Act Reauthorization of the Patient-Centered Outcomes Research Institute Repeal and Replacement of the Affordable Care Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · fourth_quarter · Q4
FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense (medical research)
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867). Proposed Alternative Payment Model for Chronic Kidney Disease care. Comments on Efficiency and Transparency Transplant Conditions of Participation, including organ discards. Comments on Proposed Rule Making for Part B drugs. Medicare Part D Protected Classes status. Increased utilization of home kidney dialysis. Medicare coverage of immunosuppressive drugs for kidney transplant recipients.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · third_quarter · Q3
FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense (medical research)
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Proposed Alternative Payment Model for Chronic Kidney Disease care Comments on ESRD Prospective Payment System and Quality Incentive Program proposed rule Comments on payment policies under the Physician Fee Schedule; Medicare Shared Savings Program; and Quality Payment Program Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · second_quarter · Q2
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2018 · first_quarter · Q1
FY 2018 and FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Comments to CMS regarding Medicare Advantage and Part D Annual Notice and Call Letter Peer Mentoring collaboration with CMS
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Comments to Dept. of Labor regarding Proposed Rule on ERISA Association Health Plans Comments to AHRQ regarding Chronic Kidney Disease Endpoints
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · fourth_quarter · Q4
Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Comments on HHS Strategic Plan for 2018-2022 Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative
Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Submitted Alternative Payment Model proposal for CKD care to CMS and HHS Comments to CMS on Dialysis Facility Compare
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867) Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Support for H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017
FY 2018 Appropriations for the Deptartment of Health and Human Services (NIH, CDC, HRSA);Food and Drug Administration; and Department of Veterans Affairs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · second_quarter · Q2
FY 2018 Appropriations for the Dept. of Health and Human Services, Food and Drug Administration, and Dept. of Veterans Affairs.
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate Comments on establishment of FDA Office of Patient Affairs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2017 · first_quarter · Q1
Implementation of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to support early detection and management of Chronic Kidney Disease Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a companion bill in the Senate
FY 17 Appropriation and FY 18 Appropriations for the Dept. of Health and Human Services, Food and Drug Administration, and Dept. of Veterans Affairs.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · fourth_quarter · Q4
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Veterans Affairs
Chronic Kidney Disease payment and delivery of care reform Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on Dialysis Facility Compare and Star Ratings Comments on Notice of Benefit and Payment Parameters
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act (including comments on inappropriate steering of individuals eligible for Medicare and Medicaid benefits to individual Marketplace plans) Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, Living Donor Protection Act S. 598 and H.R. 1130, Chronic Kidney Disease Improvement in Research and Training Act Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease Insurance discrimination and Third Party Premium Assistance
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · second_quarter · Q2
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2016 · first_quarter · Q1
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation,including S. 2584 and H.R. 4616, "Living Donor Protection Act" S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
FY 2017 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · fourth_quarter · Q4
FY 2016 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease
Medicare coverage of immunosuppressive drugs for kidney transplant recipients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · third_quarter · Q3
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease NIH Strategic Plan Framework
Comments on Physician Fee Schedule Comments on Prospective Payment System and Quality Incentive Program Medicare coverage of immunosuppressive drugs for kidney transplant recipients Comments regarding quality improvements for kidney patients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · second_quarter · Q2
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Initiatives to support early detection and management of Chronic Kidney Disease H.R. 6, "21st Century Cures Act" Comments on dietary guidelines Interoperability priorities for electronic health records
Comments to CMS on Dialysis Facility Conditions for Coverage Medicare coverage of immunosuppressive drugs for kidney transplant recipients Comments regarding quality improvements for kidney patients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2015 · first_quarter · Q1
Medicare Dialysis Five Star rating system Comments to CMS on Dialysis Facility Conditions for Coverage Medicare coverage of immunosuppressive drugs for kidney transplant recipients Comments regarding quality improvements for kidney patients
FY 2016 Appropriations for the following: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Indian Health Service
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation S. 598 and H.R. 1130, "Chronic Kidney Disease Improvement in Research and Training Act" Patient Access to drug therapies Comments to FDA on Dietary Reference intakes Initiatives in support of early detection of Chronic Kidney Disease Comments on House Energy and Commerce Committee draft "21st Century Cures" initiative
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · fourth_quarter · Q4
H.R. 4960, CARS Act of 2014"
H.R. 83, FY 2015 Appropriations for the following activities: Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Health Resources and Services Administration Indian Health Service
Implementation of the Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation, including H.R. 5263, "Living Donor Protection Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments to FDA regarding patient input on medical product discussion and patient-focused drug development Patient access to drug therapies
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act; benefits and accessibility to care Initiatives to increase and facilitate organ transplantation H.R. 5263, "Living Donor Protection Act"
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Training Act of 2014" Comments on the Medicare prospective payment system for dialysis Comments on Medicare coverage of dialysis for hospice patients Comments regarding Medicare Advantage and Part D payment issues for kidney patients
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · second_quarter · Q2
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" H.R. 4814, "Chronic Kidney Disease Improvement in Research and Treatment Act of 2014" Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Implementation of Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation
FY 2015 appropriations for Food and Drug Administration FY 2015 appropriations for Centers for Disease Control and Prevention FY 2015 appropriations for National Institutes of Health FY 2015 appropriations for Health Resources and Services Administration FY 2015 appropriations for Indian Health Service
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2014 · first_quarter · Q1
FY 2015 appropriations for Food and Drug Administration FY 2015 appropriations for CDC FY 2015 appropriations for NIH FY 2015 appropriations for Indian Health Service FY 2015 appropriations for HRSA
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Response to proposed rule to amend protected class status of immunosuppressive drugs under Medicare Part D Improving quality for kidney disease patients Comments regarding Medicare Advantage and Medicare Part D payment issues for kidney disease patients
Implementation of the Patient Protection and Affordable Care Act Initiatives to increase and facilitate organ transplantation
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · fourth_quarter · Q4
Implementation of the Patient Protection and Affordable Care Act Initiative to increase and facilitate organ transplantation Comments regarding biosimilars naming
FY 2014 Appropriations for Food and Drug Administration FY 2014 Appropriations for Chronic Kidney Disease Detection and Surveillance FY 2014 Appropriations for Indian Health Service
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Agency meeting to discuss (1) Physician Quality Reporting System and (2) Accountable Care Organizations
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
FY 2014 Appropriations for Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · second_quarter · Q2
Comments on proposed changes to the Combined Federal Campaign
Appropriations for Indian Health Service
Kidney dialysis provisions in the American Tax Payers Relief Act
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2013 · first_quarter · Q1
Design and implementation of the Patient Protection and Affordable Care Act
S. 323 and H.R. 1428, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Appropriations for Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · fourth_quarter · Q4
Integrated care delivery demonstration project for Medicare beneficiaries with chronic kidney disease.
Support for chronic kidney disease detection and surveillance initiatives.
Initiatives to increase deceased donor organ transplantation; to facilitate living organ donor transplantation; and, address quality of care issues for organ transplantation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · third_quarter · Q3
Comments on reimbursement for Intradialytic Parenteral Nutrition.
Support for chronic kidney disease detection and surveillance initiatives, through FY 2013 Appropriations.
Design and implementation of the Patient Protection and Affordable Care Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · second_quarter · Q2
Support for chronic kidney disease detection and surveillance initiatives, through FY 2013 Appropriations process.
Design and implementation of the Patient Protection and Affordable Care Act.
Implementation of chronic kidney disease and end stage renal disease provisions in the Medicare Improvement for Patients and Providers Act of 2008
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2012 · first_quarter · Q1
FY 13 Appropriations for Food and Drug Administration
Sent letter questioning Medicare plans to change health information systems for ESRD care.
Submitted comments on AHRQ report on screening and treatment for Hepatitis C
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Economic Council (NEC), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · fourth_quarter · Q4
Initiatives to increase deceased donor organ transplantation, facilitate living organ donor transplantation, address international transplantation issues, and address quality of care issues for transplantation.
Reimbursement for dialysis services.
Support for chronic kidney disease detection and surveillance initiatives.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · third_quarter · Q3
Comments regarding coverage for weight loss interventions
Comments to the Joint Select Committee on Deficit Reduction, regarding Medicare Secondary Payer in health insurance exchanges.
H.R. 860 and S. 110, to promote charitable donations of qualified vehicles.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · second_quarter · Q2
Design and implementation of various provisions of the Patient Protection and Affordable Care Act, specifically as it applies to individuals with chronic kidney disease
HR 860 and S 110, to promote charitable donations of vehicles
Appropriations for chronic kidney disease detection and surveillance initiatives
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2011 · first_quarter · Q1
HR 860 and S 110, to promote charitable donations of vehicles
Medicare Hospital Inpatient Value-based Purchasing Program measures.
Comments on lifestyle interventions for Type 2 diabetes
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · fourth_quarter · Q4
Comments concerning Leading Health Indicators for Healthy People 2020.
Comments on Medicare Physician Compare Website
FY 2011 Appropriations for chronic kidney disease detection and surveillance initiatives
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · third_quarter · Q3
FY 2011 Appropriations for Food and Drug Administration.
Comments on Comparative Effectiveness Research.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · second_quarter · Q2
FY 2011 appropriations for Indian Health Service
Allow physician assistants and nurse practitioners to order respiratory and rehabilitation services in a hospital setting
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2010 · first_quarter · Q1
FY 2011 appropriations for CKD detection and surveillance initiatives
Comments on Diabetes Research Strategic Plan
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA), White House Office
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · fourth_quarter · Q4
FY 2010 appropriations for the Indian Health Service
Recommend that Healthy People 2020 address the relationship between chronic kidney disease, diabetes, and cardiovascular disease, and address the disproportionate burden of kidney disease among members of ethnic and racial minority groups.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · third_quarter · Q3
Nutrition labeling for chronic kidney disease patients to monitor dietary calcium and potassium intake
FY 2010 appropriations for the Office of Minority Health to support expansion of a National Kidney Foundation program for detection of chronic kidney disease in high-risk populations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · second_quarter · Q2
Comments to Senate Finance Committee regarding health care reform
FY 2010 appropriations for Office of Minority Health to support expansion of a National Kidney Foundation program for detection of chronic kidney disease in high-risk populations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2009 · first_quarter · Q1
Legislative and agency initiatives to increase organ donation for transplantation.
FY 2010 appropriations for Office of Minority Health funding to support expansion of National Kidney Foundation screening program for detection of chronic kidney disease in at-risk populations.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · fourth_quarter · Q4
FY 2009 appropriations through Office of Minority Health to support expansion of the National Kidney Foundation Kidney Early Evaluation Program for detection of kidney disease in at-risk populations.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · third_quarter · Q3
Comments to proposed update to Physician Fee Schedule as it relates to payment to physicians for organ retrieval.
S. 3406, Americans with Disabilities Act (ADA) Amendments Act of 2008
FY 2009 appropriations through HHS Office of Minority Health to support expansion of the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) kidney disease detection program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · second_quarter · Q2
FY 2009 Appropriations for Indian Health Service
FY 2009 funding through HHS Office of Minority Health to support expansion of the National Kidney Foundation's Kidney Early Evaluation Program kidney disease screening (KEEP) in locations with high percentages of at-risk minority populations.
Payment for treatment of health outcomes that result from dialysis care, under Proposed Rule for Hospital Inpatient Prospective Payment System.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2008 · first_quarter · Q1
FY 2009 Appropriations for the Food and Drug Administration
End Stage Renal Disease Clincial Performance Measures Program.
FY 2009 appropriations for the Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2007 · year_end · YY
Add Potassium as a required disclosure on nutrition labels.
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities. H.R. 3282 / S. 2320, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled (Medicare "ESRD beneficiaries"). Implementation of Medicare Part D prescription drug benefit. Performance measures for chronic kidney disease under Quality Improvement Organizations. Interpretive Guidelines for Dialysis Conditions of Coverage End Stage Renal Disease Clinical Performance Measures Program CMS Coverage of Renal Stenting Malnutrition in kidney dialysis patients. H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007" Establish an educational program under Medicare for chronic kidney disease patients, to inform them of various treatment modalities.
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2007 · mid_year · MM
* Organ donation and transplant programs and activities under the Health Resources and Services Administration. H.R. 710 / S. 487, "Living Kidney Organ Donation Clarification Act," to amend the National Organ Transplant Act to clarify that kidney paired donations shall not be considered to involve the transfer of a human organ for valuable consideration. Medicare coverage of erythropoiesis stimulating agents for individuals with chronic kidney failure. Include chronic kidney disease screening in the Preventive Services Task Force recommendations. Recommendation to include chronic kidney disease under Evidence-Based Practice Centers Program activities Labeling requirements for over-the-counter Anti-inflammatory medications
* H.R. 1245 / S. 432, "Kidney Disease Educational Benefits Act of 2007," to establish a Medicare benefit to provide kidney dialysis and kidney transplant therapy information to individuals with chronic kidney disease, before they require kidney replacement therapy. H.R. 1193/S. 691, "Kidney Care Quality and Education Act of 2007," to improve benefits under the Medicare End Stage Renal Disease program, and for other purposes. H.R. 3282, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007," to extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients who are not Medicare-aged or Medicare-disabled. Implementation of Medicare Part D prescription drug benefit. Performance Measures for chronic kidney disease under Quality Improvement Organizations
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2006 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2005 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2005 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2004 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Indian Health Service, SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2004 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Treasury, Dept of
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2002 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2001 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2000 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
2000 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
1999 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE
NATIONAL KIDNEY FOUNDATION via NATIONAL KIDNEY FOUNDATION
1999 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to expand access to home dialysis (bill introduction pending). S.1973 and H.R. 4231, "Treat and Reduce Obesity Act," to provide Medicare coverage of anti-obesity medications and obesity treatment. Opposed changes to Medicaid eligibility, access and affordability of coverage under the One Big Beautiful Bill (H.R. 1). Activities to address detection and management of chronic kidney disease. Support for Medicare Part D Protected Classes. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to expand access to home dialysis. Medicare coverage of anti-obesity medications. Support for Medicare Part D Protected Classes. Access to Medicaid. Implementation of the Advancing American Kidney Health Initiative.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
H.R. 8075, Improving Access to Home Dialysis Act. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, S. 4510 "Kidney PATIENT Act of 2023" H.R. 6860, S. 5018 "Restore Protections for Dialysis Patients Act." H.R. 7856, S. 4094, "PREVENT Diabetes Act." Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes coverage. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality. Comments on Medicare $2 Drug List Model RFI.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544 (P.L. 118-14), "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of people with kidney disease. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and benefits, including H.R. 1692 "Health Care Affordability Act." Prescription drug pricing and access. Comments to HRSA to update criteria for post-transplant graft survival metrics. Comments to HRSA on the HIV Organ Policy Equity (HOPE) Act of 2013 (P.L. 113-51)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
FY 2025 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2025 Appropriations for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2025 Appropriations for the National Heart, Lung and Blood Institute. FY 2025 Appropriations under the Health Resources and Services Administration, with emphasis on organ donation and transplant activities. FY 2025 Appropriations for the Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
FY 2024 and FY 2025 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2024 and FY 2025 Appropriations for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2025 Appropriations for the National Heart, Lung and Blood Institute. FY 2024 and FY 2025 Appropriations for organ donation and transplant activities under the Health Resources and Services Administration. FY 2024 Appropriations for the Indian Health Service.
Improving access and utilization of home dialysis for Medicare beneficiaries, including draft legislation to authorize Medicare reimbursement for in-home assistance by dialysis providers. Inflation Reduction Act Medicare drug pricing, including Medicare Part D Redesign Program Guidance. Support for Medicare Part D Protected Classes. Medicare payment for dental services for ESRD beneficiaries receiving dialysis. Comments on CY 2025 Advanced Notice of Changes to Medicare Advantage Capitation, Part C and Part D. Kidney patient health and management under Medicare Advantage. Medicare activities and coverage for COVID-19 patients. Protect Medicaid eligibility. S. 2407, H.R. 4818, the "Treat and Reduce Obesity Act" S. 1832, H.R. 3842, "Expanding Access to Diabetes Self-Management Training Act" H.R. 5074, "Kidney PATIENT Act of 2023" H.R. 6860, "Restore Protections for Dialysis Patients Act." Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address rural health access and quality.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. H.R. 2544, "Securing the U.S. Organ Procurement and Transplantation Network Act." H.R. 6020, "Honor Our Living Donors Act." H.R. 6171, "Living Organ Donor Tax Credit Act." Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access and data standardization initiatives. Activities to address chronic disease and metabolic disorders. Activities regarding implementation of HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
FY 2024 Appropriations for the Department of Health and Human Services programs. FY 2024 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2024 Appropriations for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. Funding for organ donation and transplant activities under HRSA and HHS. FY 2024 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
H.R. 2923 and S. 1384, "Living Donor Protection Act of 2023", to prohibit discrimination in the issuing, pricing and benefits amount of life, disability, or long-term care insurance policies for living organ donors. Initiatives and activities to increase, improve, and facilitate organ donation and transplantation, including equity in transplant access. Comments on NIH Postdoctoral program and activities. Comments on FTC Non-Compete Clause proposed rulemaking. Activities regarding HHS Advancing American Kidney Health Initiative. Activities to address COVID-19 and the needs of dialysis patients and kidney transplant recipients. Activities to address ethnic, racial and social disparities in health and access to care. Telemedicine and telehealth access. Affordable Care Act access, utilization and Essential Health Benefits. Prescription drug pricing and access.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
FY2023 and FY 2024 Appropriations for the Department of Health and Human Services, including CDC, NIH and HRSA. Funding increases for CDC Chronic Kidney Disease Initiative. Funding increase for kidney disease research at the National Institute of Diabetes and Digestive and Kidney Diseases. Funding for organ donation and transplant activities under HRSA and HHS. FY2023 and FY 2024 funding for Indian Health Service.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to increase, improve and facilitate organ donation and transplantation. S. 377 and H.R. 1255, the "Living Donor Protection Act," to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. H.R. 7506, "The New Era of Preventing End Stage Renal Disease Act." Activities to address COVID-19 impact and needs of kidney patients and caregivers, including supply change disruptions; prioritization for access to vaccination for dialysis patients and kidney transplant recipients; and, priority access to specific COVID-19 prescriptions. Letter to HHS Advisory Committee of Blood and Tissue Safety re: HIV Organ Policy Equity (HOPE) Act of 2013. Letter to FDA in support of the Kidney Health Initiative and Kidney Innovation Accelerator (KidneyX). Healthy People 2030. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care and in chronic kidney disease detection, prevention, management and care. Activities included H.R. 7585, the Health Equity and Accountability Act (HEAA). H.R. 5030/S.2706, DIVERSE Trials Act to address clinical trails participation barriers by underrepresented patient populations. H.R. 7667, PDUFA reauthorization (support for clinical trial diversity provisions). Expand access to telemedicine. Support for limits on insulin prices for consumers. Prescription drug pricing and access. Affordable Care Act access and utilization, including comments on the ACA Nondiscrimination Proposed Rule.
FY 2023 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding for a Chronic Kidney Disease Risk Campaign public awareness initiative. Increase funding for CDC's Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Submitted comments on Proposed Rules for the ESRD Prospective Payment System, ESRD Quality Incentive Program, and ESRD Treatment Choices Model. Submitted comments on Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System. Submitted comments on Proposed 2023 Payment Policies under the Physician Fee Schedule. Responded to RFI on Medicare Advantage. H.R. 8594 and S. 4750, "Restore Protections for Dialysis Patients Act," to provide Medicare access to kidney dialysis. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. Support for Kidney Health Evaluation (KED) for patients with diabetes. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Participated in health community effort to urge HHS to expand Medicare coverage to include medically necessary dental treatments for solid organ transplant recipients and other vulnerable individuals.
FY 2023 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding for a Chronic Kidney Disease Risk Campaign public awareness initiative. Increase funding for CDC's Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including supply change disruptions; prioritization for access to vaccination for dialysis patients and kidney transplant recipients; and, priority access to specific COVID-19 prescriptions. Comments on the Strategic National Stockpile. Healthy People 2030. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care and in chronic kidney disease detection, prevention, management and care. Activities included H.R. 7585, the Health Equity and Accountability Act (HEAA). H.R. 5030/S.2706, DIVERSE Trials Act to address clinical trails participation barriers by underrepresented patient populations. H.R. 7667, PDUFA reauthorization (support for clinical trial diversity provisions). Expand access to telemedicine. Support for limits on insulin prices for consumers. Prescription drug pricing and access. Affordable Care Act access and utilization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation. S. 377 and H.R. 1255, Living Donor Protection Act to prohibit discrimination in the issuing, pricing, and benefits level of life, disability or long-term care insurance for living organ donors. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including supply change disruptions; prioritization for access to vaccination for dialysis patients and kidney transplant recipients; and, priority access to specific COVID-19 prescriptions. Comments on the Strategic National Stockpile. Healthy People 2030. Activities regarding the HHS Advancing American Kidney Health Initiative. Initiatives to address ethnic, racial and social disparities in health care and in chronic kidney disease detection, prevention, management and care. H.R. 5030/S.2706, DIVERSE Trials Act to address clinical trails participation barriers by underrepresented patient populations. Expand access to telemedicine. Prescription drug pricing and access. Affordable Care Act access and utilization.
FY 2022 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. FY 2023 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding for a Chronic Kidney Disease Risk Campaign public awareness initiative. Increase funding for CDC's Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Activities to address access and utilization of home dialysis, including H.R. 5426, the "Improving Access to Home Dialysis Act of 2021" to authorize Medicare reimbursement for staff-assisted home dialysis and for other purposes. Support for Protected Classes under Medicare Part D program. H.R. 1676, provide access to Medigap coverage for Medicare end-stage kidney disease patients under age 65. These Medicare beneficiaries do not have a guaranteed opportunity to purchase a Medigap policy. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. Legislation would expand coverage of nutrition therapy services to additional diseases and conditions and expand the types of medical providers for such services. S. 2203, H.R. 5804, Medicare Diabetes Self-Management Training Act. Expands coverage of diabetes outpatient self-management training. S. 2173, H.R. 2807, PREVENT DIABETES Act. Requires Medicare to offer its Diabetes Prevention Program in a virtual or online format. S. 1512 and H.R. 2903, "CONNECT for Health Act." Expands coverage of telehealth services under Medicare. S. 596 and H.R. 1577, the "Treat and Reduce Obesity Act," to expand the types of health professionals permitted to provide weight loss management and counseling services under Medicare Part B and to include coverage of weight loss management drugs under Medicare Part D. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Request to expedite the rulemaking process following the 116th Congress enactment of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (H.R. 5534, S. 3353) to provide Medicare Part B coverage of anti-rejection medications for kidney transplant recipients who lack private, group or other public health insurance coverage for these medications.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
FY 2022 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; and Indian Health Service. Request HHS funding of a Chronic Kidney Disease Risk Campaign public awareness initiative. Support for CDC's existing Chronic Kidney Disease program. Kidney disease research funded by National Institutes of Health. Funding for organ transplant activities under HHS and HRSA.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Support for Protected Classes under Medicare Part D program. Support for H.R. 1676, provide Medigap coverage for Medicare end-stage kidney disease patients under age 65. S. 1536, H.R. 3108, Medicare Medical Nutrition Therapy Act. S. 2203, Medicare Diabetes Self-Management Training Act. S. 2173, H.R. 2807, PREVENT DIABETES Act. Activities to address access and utilization of home dialysis. Support for COVID-19 patients (telehealth, home dialysis, copayment waivers, regulatory waivers). Comments to CMS on the Proposed FY 2022 Hospital IPPS rule.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation. Comments to HHS regarding Organ Procurement Organization Conditions for Coverage. S. 377 and H.R. 1255, Living Donor Protection Act. Activities to address COVID-19 impact and needs of kidney patients and caregivers, including prioritization for access to vaccination for dialysis patients and kidney transplant recipients. Telemedicine access. Activities to address access and utilization of home dialysis. Activities regarding the HHS Advancing American Kidney Health Initiative. Early detection and management of Chronic Kidney Disease, including recommendation to provide CKD screening in Federally Qualified Health Centers. Initiatives to address ethnic, racial and social disparities in Chronic Kidney Disease detection, prevention, management and care. Prescription drug pricing and access. Affordable Care Act access and utilization.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model. Increased utilization of home dialysis and other home health benefits. Extension of Medicare Part B coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353). Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Activities in response to COVID-19, including supplies of PPE, access to telemedicine, access to remote laboratory services, improved access to home dialysis, access to kidney transplantation, waiver of copayments, expanded access to insurance coverage, disparities issues, waiver of various regulatory requirements. Early detection and management of Chronic Kidney Disease Initiatives related to ethnic, racial and social health disparities Prescription Drug Pricing and Access Management of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY 2021 Appropriations for the Department of Health and Human Services (HHS,NIH,NIDDK,CDC,HRSA); Food and Drug Administration; Indian Health Service, Department of Veterans Affairs, Department of Defense. Request for HHS funding to support a proposed Chronic Kidney Disease public awareness initiative. Funding to support various kidney disease and organ donations activities under HHS agencies. General Appropriations for FDA, IHS,DoD medical research, Veterans Affairs medical research.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients (H.R. 5534; S. 3353 Comments on the Advanced Notice for Medicare Advantage Capitation and Part C and Part D payments Activities in response to COVID-19,including expanding access to telehealth, access to home kidney dialysis, access to kidney transplantation, waiver of patient copayments, and waiver of certain regulatory requirements. Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation, including the Living Donor Protection Act (S. 511 / H.R. 1224); the National Living Donor Assistance Center; increased utilization of Kidney Discards Activities in support of HHS Advancing American Kidney Health initiative Early detection and management of Chronic Kidney Disease Department of Health and Human Services Million Hearts initiative Department of Health and Human Services KidneyX initiative Comments on Donation Service Areas for organ allocation Comments on Public Health Service Guidelines on organ allocation and utilization Prescription Drug Pricing and Access Reauthorization of the Patient-Centered Outcomes Research Institute Management of the Affordable Care Act Repeal and Replacement of the Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY 2020 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Indian Health Service, Veterans Affairs, and Department of Defense
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Medicare Advantage Step Therapy Modification of ICD-10-CM Codes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill. Comments on proposed policies by the Organ Procurement and Transplantation Network and United Network for Organ Sharing. Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. Health and Human Services Million Hearts initiative. Health and Human Services KidneyX initiative. Management of the Patient Protection and Affordable Care Act. Repeal and Replacement of Affordable Care Act.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Prescription Drug Pricing H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Health and Human Services Million Hearts initiative Health and Human Services KidneyX initiative Comments on Patient Focused Drug Development Draft Guidance for Industry Comments on Physician-focused Payment Model Technical Advisory Committee preliminary review and model consideration process Management of the Patient Protection and Affordable Care Act Repeal and Replacement of Affordable Care Act
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE
FY 2018 Appropriations for the Deptartment of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
Chronic Kidney Disease payment and delivery of care reform Medicare Access and CHIP Reauthorization Act (MACRA)implementation Medicare Advantage Risk Adjustment Kidney disease quality measures H.R. 5659, ESRD Choice Act H.R. 6139, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on Physician Fees Schedule and MA Provider Network requirements Comments on Transplant Outcomes Measures and Organ Procurement Organization Reporting
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Veterans Affairs, Dept of (VA), White House Office
Chronic Kidney Disease payment and delivery reform Medicare Access and CHIP Reauthorization Act (MACRA)implementation Medicare Advantage Risk Adjustment Kidney disease quality measures Third Party insurance premium payment Medicare coverage of immunosuppressive drugs for kidney transplant recipients
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office
Chronic Kidney Disease payment and delivery reform Comments on dialysis vascular access and transplant measures Comments on dialysis Five Star methodology Comments on Medicare Access and CHIP Reauthorization Act (MACRA) Third Party insurance premium payment Medicare coverage of immunosuppressive drugs for kidney transplant recipients
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY 2016 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
FY 2016 Appropriations for: Department of Health and Human Services Food and Drug Administration Centers for Disease Control and Prevention National Institutes of Health Heath Resources and Services Administration Indian Health Service
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
S. 323 and H.R. 1428, "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act" H.R. 4188, "Establishing Beneficiary Equity in the Hospital Readmission Program Act" Medicare Dialysis Five Star Rating proposal
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
FY 2015 Appropriations for Food and Drug Administration FY 2015 Appropriations for Centers for Disease Control and Prevention FY 2015 Appropriations for National Institutes of Health FY 2015 Appropriations for Health Resources and Services Administration FY 2015 Appropriations for Indian Health Service
H.R. 4960, "CARS Act of 2014"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Implementation of the Patient Protection and Affordable Care Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Personnel Management (OPM), SENATE
H.R. 860 and S. 110, to promote charitable donations of qualified vehicles.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
Comments regarding participation of nephrologists and dialysis clinics in "meaningful use" for Health Information Technology.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), SENATE
Comment letter regarding methods for assuring access for covered Medicaid services
Appropriations for Indian Health Service
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
Appropriations for chronic kidney disease detection and surveillance initiatives
Appropriations for Indian Health Service
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, SENATE
H.R. 571, modifying tax deduction valuation of vehicle donations for charity purposes.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
* Inclusion of chronic kidney disease in Healthy People 2020 guideline. Medicare coverage of erythropoiesis stimulating agents (ESA's) for individuals with chronic kidney disease or chronic kidney failure. FDA labeling issues related to ESA's. Inclusion of chronic kidney disease in Healthy People 2020 guideline.
* Annual appropriations for Food and Drug Administration Funding for organ donation programs under the Health Resources and Services Administration. Annual appropriations for Food and Drug Administration
FY 2008 Appropriations for Indian Health Service.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
* Continued funding for and implementation of a chronic kidney disease program at the Centers for Disease Control and Prevention; H.R. 3043 / S. 1710, FY 08 Labor, HHS, Education Appropriations Bill. Increase funding for the Food and Drug Administration H.R. 3161 / S. 1859, FY 08 Agriculture Appropriations Bill
Add Potassium as a required disclosure on nutrition labels.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE